Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.31%), DAX +0.07%, CAC (1.00%)

Apr 17 ,2025

  • Synopsis

    • European equity markets are set to open mixed to lower amidst Asian equities mostly higher Thursday. Sentiment turning positive with Hang Seng leading China markets despite latest US tech crackdown reports. Japan, Korea and Australia also firmer. Taiwan lagging though off worst levels. S&P 500 futures rebounding afterhours. Bonds mixed with Treasury yields moving higher, but JGB yields lower at the long end. Australian and New Zealand yields remain lower following latest data. Dollar seeing broad gains against other currencies. Crude adding to earlier gains while gold steady and copper pulling lower. Bitcoin seeing mild decline.

    • Focus on ECB rate decision with ECB expected to cut its benchmark interest rate by (25bps) to 2.25% when it announces its outcome at 14:15CET, press conf 14:45. Also in central banks, BOE releases its latest Credit Conditions Survey at 9:30BST. Elsewhere, IMF Director Georgieva delivers speech before the start of the IMF-World Bank Spring meetings. In politics, Portugal general election tv debates on SIC at 21:00CET (Pedro Nuno Santos (PS) x Rui Tavares (Livre)) and on RTP3 at 22:00 (André Ventura (Chega) x Rui Rocha (IL)). In other events, EU Meets the Balkans Forum, speakers include EU's Kos.

    • Macroeconomic updates today include: Germany Apr ZEW survey, France Mar final CPI, UK Feb unemployment rate, Mar claimant count change, retail sales monitor - BRC, Norway Mar trade balance, Eurozone Feb industrial production

    • In corporate news, Siemens Energy (ENR.GR) released yesterday after the close prelim Q2 numbers. Still in the DACH region, ABB Limited (ABBN.SW) reported this morning Q1 earnings and announced to spin off ABB Robotics into separate, listed company. Evotec (EVT.GR) is also out with Q4 figures. In France, bioMerieux (BIM.FP) reported Q1 sales and confirmed FY25 outlook. ATOS (ATO.FP) reported Q1 revenue €2.07B, (17%) y/y and Pernod Ricard (RI.FP) posted Q3 sales and confirmed FY outlook. From the Benelux, Basic-Fit (BFIT.NA) released Q1 update whilst TomTom (TOM2.NA) is due to update investors today.

    • CMD/events: Evotec (EVT.GR) Cell & Gene Meeting

  • Politics/Macro/World News

    • China seeks reset with EU amid Donald Trump's trade war - FT

    • EU centre-right vows to stick to firewall to defeat Europe's 'authoritarian wave' - FT

    • ECB to Cut Rates Again as Tariffs Imperil Growth - Bloomberg

    • Spain and Lithuania push to oust Ireland from leading eurozone talks - Politico

    • US' Rubio will meet French foreign minister on Thursday, source says - Reuters

    • Italy's Meloni heads to US with unlikely mission for Europe - BBC

    • WTO slashes 2025 trade growth forecast, warns of deeper slump - Reuters

  • Top company news

    • Earnings/updates

      • DACHs

        • ABBN.SW (ABB Limited) -- reports Q1 EPS $0.60 vs consensus $0.53, guides Q2, reaffirms 2025 outlook

        • ENR.GR (Siemens Energy) -- reports preliminary Q2 profit before special Items €906M vs year-ago €170M

        • RHM.GR (Rheinmetall) -- expects order volume to grow to up to €300B over next five years - Handelsblatt

        • VACN.SW (VAT Group) -- reports Q1 revenue CHF275.1M vs StreetAccount CHF283.1M

        • EVT.GR (Evotec) -- reports Q4 adj. EBITDA €22.6M vs FactSet €27.2M [1 est]; guides FY25 adj. EBITDA in range of €30 - 50M vs FactSet €77.41M

      • Southern Europe

        • MONC.IM (Moncler) -- reports Q1 revenue €829M vs StreetAccount €816.8M

        • BC.IM (Brunello Cucinelli) -- reports Q1 revenue €341.5M vs StreetAccount €339.6M; confirms expectation of ending 2025 with an increase in turnover of around 10%

        • MFEB.IM (MFE-MEDIAFOREUROPE) -- reports FY results in line with prelim announcement; increase in dividend to €0.27 (+8% vs 2023) will be proposed

      • France

        • BIM.FP (bioMerieux) -- reports Q1 sales €1.10B vs FactSet €1.08B [3 est, €1.05-1.10B]; confirms FY25 sales guidance and closely monitoring evolving tariff situation

        • ADP.FP (Aeroport de Paris) -- reports Mar total Paris Aeroports traffic 8.04M, +0.7% y/y

        • EMEIS.FP (Emeis SA) -- reports FY24 net income (€412M) vs FactSet (€361.2M)

        • COV.FP (Covivio) -- reports Q1 revenue €162.3M, +6% vs year-ago €153.6M

        • POXEL.FP (Poxel) -- provides financial update for Q1 of 2025 and announces the postponement of its 2024 full-year results; company has limited cash runway

        • ICAD.FP (Icade) -- reports H1 revenue €326.0M vs year-ago €322.0M

        • ATO.FP (ATOS SE) -- reports Q1 revenue €2.07B, (17%) vs year-ago €2.48B

        • RI.FP (Pernod Ricard) -- reports Q3 net sales €2.28B vs consensus €2.28B; confirms FY25 outlook but geopolitical environment remains challenging and very fluid with regards to tariffs

        • IPS.FP (Ipsos)-- reports Q1 revenue €568.5M vs FactSet €570.0M [1 est]

        • FRVIA.FP (Forvia) -- reports Q1 revenue €6.70B vs FactSet €6.54B [2 est, €6.54-6.54B]; confirms FY25 guidance

      • Benelux

        • WHA.NA (Wereldhave) -- Q1 trading update: reports direct result per share (DRPS) € 0.44, +7% y/y

        • CMCOM.NA (CM.com) -- reports Q1 normalized EBITDA €3.9M vs year-ago €3.3M

        • NSI.NA (NSI NV) -- Q1 Trading Update: EPRA EPS €0.42 vs year-ago €0.35; reaffirms FY EPRA EPS guidance

        • BFIT.NA (Basic-Fit) -- reports Q1 revenue €332M, +17% vs year-ago €284M; outlook as provided at FY24 Results reiterated

      • Nordics

        • ELISA.FH (Elisa Oyj) -- reports Q1 comparable EPS €0.58 vs FactSet €0.58 [9 est, €0.56-0.60]

    • M&A

      • INPST.NA (InPost) -- acquires Yodel via debt-to-equity conversion

      • SPIE.FP (SPIE) -- to acquire LTEC Group; terms not disclosed

    • Healthcare

      • BAVA.DC (Bavarian Nordic A/S) -- Bavarian Nordic A/S's Chikungunya vaccine receives recommendation from U.S. CDC's advisory committee on Immunization practices (ACIP)

      • ADXN.SW (Addex Therapeutics) -- announces Janssen Pharmaceuticals has returned all development and commercialization rights to ADX71149 (JNJ-40411813) and the partnership between the two companies has been terminated

    • Other

      • ABBN.SW (ABB Limited) -- ABB to spin off ABB Robotics into separate, listed company

      • EQNR.NO (Equinor) -- US halts Equinor's Empire Wind project

      • ML.FP (Cie Generale des Etablissements Michelin SA) -- Michelin publishes global tire market data for Mar

      • ARCAD.NA (ARCADIS) -- announces new design services framework with London Gatwick

  • Key rating changes

    • Upgrades

      • ANTO.LN (Antofagasta) -- to sector perform from underperform at RBC Capital Markets

    • Downgrades

      • BNZL.LN (Bunzl) -- to neutral from overweight at JPMorgan

    • Initiations

      • JET2.LN (Jet2) -- overweight at JPMorgan

  • Data

    • Nikkei +1.10% to 34292.89

    • Hang Seng +1.25% to 21319.79

    • Shanghai Composite (0.04%) to 3274.73

    • S&P futures +46.3 vs prior close of 5305.8

    • €-$ (0.0052) or (0.46%) to 1.1348

    • $-¥ +0.91 or +0.64% to 142.80

    • €-¥ +0.37 or +0.23% to 162.04

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE